Remdesivir is least likely to be effective for safe treatment of COVID-19: A pharmacovigilant point of view
This manuscript has been published on the 29 th of May 2020 by the honorable BMJ as a rapid response to a related article. However since a DOI has not been assigned and two subsequent manuscripts have cited it, I’m preprinting a copy wishing it might reach all the interested colleagues and researchers in an easier way.
1962 ◽
Vol 14
◽
pp. 169-257
◽
Keyword(s):
1984 ◽
Vol 75
◽
pp. 331-337
1983 ◽
Vol 41
◽
pp. 174-177
Keyword(s):
1982 ◽
Vol 40
◽
pp. 600-603
1978 ◽
Vol 36
(2)
◽
pp. 412-413
1978 ◽
Vol 36
(1)
◽
pp. 484-485
Keyword(s):
1984 ◽
Vol 42
◽
pp. 70-73
1972 ◽
Vol 30
◽
pp. 80-81
1991 ◽
Vol 49
◽
pp. 452-453
Keyword(s):
1986 ◽
Vol 44
◽
pp. 396-397